These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 39247793)

  • 21. Zishen Qingre Lishi Huayu Recipe May Ameliorate the Symptoms of PCOS Model Rats via Alleviating Systemic and Ovarian Inflammation.
    Li X; Yi Y; Ren Y; Zhang Y; Wang CC; Liu C; Liu S; Zhan X; Yu X; Liang R
    Am J Reprod Immunol; 2024 Aug; 92(2):e13918. PubMed ID: 39158962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimethyl itaconate mitigates histological distortions, inflammation, and oxidative stress in the rat model of polycystic ovary syndrome.
    Hosseinkhani F; Hosseinifar S; Tabandeh MR
    J Steroid Biochem Mol Biol; 2024 Oct; 243():106546. PubMed ID: 38754523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells.
    Liu Y; Li Z; Wang Y; Cai Q; Liu H; Xu C; Zhang F
    Front Endocrinol (Lausanne); 2022; 13():787876. PubMed ID: 35250857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis.
    Peng Q; Chen X; Liang X; Ouyang J; Wang Q; Ren S; Xie H; Wang C; Sun Y; Wu X; Liu H; Hei C; Sun M; Chang Q; Liu X; Li G; He R
    Front Endocrinol (Lausanne); 2023; 14():1070264. PubMed ID: 36755918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interlukin-22 improves ovarian function in polycystic ovary syndrome independent of metabolic regulation: a mouse-based experimental study.
    Chen W; Liao B; Yun C; Zhao M; Pang Y
    J Ovarian Res; 2024 May; 17(1):100. PubMed ID: 38734641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
    He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
    Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine exerts a protective effect on rats with polycystic ovary syndrome by inhibiting the inflammatory response and cell apoptosis.
    Shen HR; Xu X; Li XL
    Reprod Biol Endocrinol; 2021 Jan; 19(1):3. PubMed ID: 33407557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
    Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
    Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catalpol attenuates polycystic ovarian syndrome by regulating sirtuin 1 mediated NF-κB signaling pathway.
    Zhao J; Tan Y; Feng Z; Zhou Y; Wang F; Zhou G; Yan J; Nie X
    Reprod Biol; 2022 Sep; 22(3):100671. PubMed ID: 35905692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
    Huang Y; Zhang X
    Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.
    Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH
    PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guizhi Fuling Wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway.
    Liu M; Zhu H; Zhu Y; Hu X
    J Ethnopharmacol; 2021 Apr; 270():113821. PubMed ID: 33460753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnolol Alleviates IL-1β-Induced Dysfunction of Chondrocytes Through Repression of SIRT1/AMPK/PGC-1α Signaling Pathway.
    Liu Z; Zhang H; Wang H; Wei L; Niu L
    J Interferon Cytokine Res; 2020 Mar; 40(3):145-151. PubMed ID: 31916911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metformin improves polycystic ovary syndrome and activates female germline stem cells in mice].
    Wang CH; Wang QQ; Su YS; Sun YQ; Sun M; Liu XR; Ma HM; Li GY; DU XL; He R
    Sheng Li Xue Bao; 2022 Jun; 74(3):370-380. PubMed ID: 35770635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome.
    Wu H; Yang M; Yan C; Liu M; Wang H; Zhang W
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38666538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of LncRNA steroid receptor RNA activator attenuates polycystic ovary syndrome in mice.
    Li Y; Zhao W; Wang H; Chen C; Zhou D; Li S; Zhang X; Zhao H; Zhou D; Chen B
    Biochimie; 2019 Feb; 157():48-56. PubMed ID: 30391287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
    Xue J; Li X; Liu P; Li K; Sha L; Yang X; Zhu L; Wang Z; Dong Y; Zhang L; Lei H; Zhang X; Dong X; Wang H
    Endocr J; 2019 Oct; 66(10):859-870. PubMed ID: 31270279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arctigenin derivative A-1 ameliorates motor dysfunction and pathological manifestations in SOD1
    Xiong B; Yang C; Yang X; Luo S; Li S; Chen C; He K; Nie L; Li P; Li S; Huang H; Liu J; Zhang Z; Xie Y; Zou L; Yang X
    CNS Neurosci Ther; 2024 Jun; 30(6):e14692. PubMed ID: 38872258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.